Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vogl

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Therapeutic Drug Monitoring|December 22, 1999
Evaluation of the EMIT Mycophenolic Acid Assay from Dade BehringM Vogl, G Weigel, G Seebacher, et al.
Anticancer Research|April 5, 2017
Evaluation of Prognostic Immune Signatures in Patients with Breast, Colorectal and Pancreatic Cancer Receiving ChemotherapyUrsula M Vogl, Leopold Öhler, Masa Rasic, et al.
ACS Nano|October 16, 2024
Unraveling Interdiffusion Phenomena and the Role of Nanoscale Diffusion Barriers in the Copper-Gold SystemLilian M Vogl, Peter Schweizer, Xavier Maeder, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 6, 1998
Noninvasive monitoring using serum amyloid A and serum neopterin in cardiac transplantationT F Müller, M Vogl, M C Neumann, et al.
ACS Nano|August 21, 2025
Deformation and Failure of Supported Five-Fold Twinned Silver Nanowires under Tensile, Compressive, and Cyclic LoadingMarco Moninger, Lilian M Vogl, Peter Schweizer, et al.
British Journal of Cancer|August 31, 2006
Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variableU M Vogl, H Zehetgruber, M Dominkus, et al.
BMC Cancer|January 10, 2019
Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?Ursula M Vogl, Haleh Andalibi, Alexander Klaus, et al.
Pharmacoeconomics - Open|February 9, 2023
Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in SwitzerlandEsra Çakar, César Oniangue-Ndza, Ralph P Schneider, et al.
Annals of the New York Academy of Sciences|February 25, 2009
Immunology, signal transduction, and behavior in hypothalamic-pituitary-adrenal axis-related genetic mouse modelsSusana Silberstein, Annette M Vogl, Juán José Bonfiglio, et al.
Neuroscience|April 14, 2009
Amygdaloid pERK1/2 in corticotropin-releasing hormone overexpressing mice under basal and acute stress conditionsS Silberstein, A M Vogl, D Refojo, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Therapeutic Drug Monitoring|December 22, 1999
Evaluation of the EMIT Mycophenolic Acid Assay from Dade BehringM Vogl, G Weigel, G Seebacher, et al.
Anticancer Research|April 5, 2017
Evaluation of Prognostic Immune Signatures in Patients with Breast, Colorectal and Pancreatic Cancer Receiving ChemotherapyUrsula M Vogl, Leopold Öhler, Masa Rasic, et al.
ACS Nano|October 16, 2024
Unraveling Interdiffusion Phenomena and the Role of Nanoscale Diffusion Barriers in the Copper-Gold SystemLilian M Vogl, Peter Schweizer, Xavier Maeder, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 6, 1998
Noninvasive monitoring using serum amyloid A and serum neopterin in cardiac transplantationT F Müller, M Vogl, M C Neumann, et al.
ACS Nano|August 21, 2025
Deformation and Failure of Supported Five-Fold Twinned Silver Nanowires under Tensile, Compressive, and Cyclic LoadingMarco Moninger, Lilian M Vogl, Peter Schweizer, et al.
British Journal of Cancer|August 31, 2006
Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variableU M Vogl, H Zehetgruber, M Dominkus, et al.
BMC Cancer|January 10, 2019
Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?Ursula M Vogl, Haleh Andalibi, Alexander Klaus, et al.
Pharmacoeconomics - Open|February 9, 2023
Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in SwitzerlandEsra Çakar, César Oniangue-Ndza, Ralph P Schneider, et al.
Annals of the New York Academy of Sciences|February 25, 2009
Immunology, signal transduction, and behavior in hypothalamic-pituitary-adrenal axis-related genetic mouse modelsSusana Silberstein, Annette M Vogl, Juán José Bonfiglio, et al.
Neuroscience|April 14, 2009
Amygdaloid pERK1/2 in corticotropin-releasing hormone overexpressing mice under basal and acute stress conditionsS Silberstein, A M Vogl, D Refojo, et al.
Pageof 6